You are here
ESSCB Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras
On November 14, 2011, the ESSCB Funding Committee voted to adopt a Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras, which was developed and...
New Model Informed Consent Forms
ESSCB Model Informed Consent Forms On November 14, 2011, the ESSCB Funding Committee approved five model informed consent forms developed by the ESSCB Ethics Committee. The forms provide guidance...
Michel Sadelain recognized for Thalassemia work
Dr. Michel Sadelain, at Memorial Sloan-Kettering Cancer Center, was recognized for his efforts to develop a new stem cell-based therapy for β-thalassemia patients by the Sultan Bin Khalifa International Thalassemia Award.
Endothelial Cells Show Tissue-Specificity
A new paper from Shahin Rafii's lab profiles endothelial cells and finds they have tissue-specific characteristics.
Nail Stem Cells Coordinate Nail Growth and Digit Regrowth
A new paper published in Nature from the lab of Mayumi Ito at NYU describes the role of nail stem cells in coordinating both nail growth and regrowth of digit-tips after amputation in mice.
Stimulation of Endogenous Neural Progenitor Cells Slows the Progression of Huntington’s Disease
Glioma Progenitor Cells Have a Unique Gene Expression Profile
New research from Steven Goldman’s lab identifies potential therapeutic targets in glioma tumor progenitor cells.
NANOG Recruitment of TET Aids Reprogramming
Jianlong Wang, Ph.D., and colleagues report that NANOG aids in reprogramming to establish pluripotency by recruiting TET proteins that act to remove DNA methylation.
A New Cell-Based Therapy to Treat Leukemia
Investigators at Memorial Sloan-Kettering use genetic engineering of T-cells to target cancerous B-cells in patients.
A New Source of Cancer in the Ovary
Drs. Alex Nikitin and Grigori Enikolopov identify a stem cell niche in ovarian epithelium that is disposed to cancer.
NYSTEM Funded Scientist Receives Audacious Idea Prize From National Eye Institute
NYSTEM funded scientist and clinician, Dr. Jeffrey Stern, receives Audacious Idea prize from the NEI to repair retina by activating resident stem cells.
Novel Scientific Technique to Help Prevent Inherited Mitochondrial Diseases
Dieter Egli, PhD, of the New York Stem Cell Foundation (NYSCF) and Mark Sauer, MD, at the Columbia University Medical Center developed a novel technique to prevent the transmission of defective mitochondria in humans.